AU2001273102A1 - Crystal structure of survivin - Google Patents

Crystal structure of survivin

Info

Publication number
AU2001273102A1
AU2001273102A1 AU2001273102A AU7310201A AU2001273102A1 AU 2001273102 A1 AU2001273102 A1 AU 2001273102A1 AU 2001273102 A AU2001273102 A AU 2001273102A AU 7310201 A AU7310201 A AU 7310201A AU 2001273102 A1 AU2001273102 A1 AU 2001273102A1
Authority
AU
Australia
Prior art keywords
survivin
crystal structure
crystal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001273102A
Inventor
Han-Kuei Huang
Tony Hunter
Joseph P. Noel
Mark Verdacia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Salk Institute for Biological Studies
Original Assignee
Salk Institute for Biological Studies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salk Institute for Biological Studies filed Critical Salk Institute for Biological Studies
Publication of AU2001273102A1 publication Critical patent/AU2001273102A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
AU2001273102A 2000-06-29 2001-06-29 Crystal structure of survivin Abandoned AU2001273102A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60835200A 2000-06-29 2000-06-29
US09/608,352 2000-06-29
PCT/US2001/020872 WO2002002622A2 (en) 2000-06-29 2001-06-29 Crystal structure of survivin

Publications (1)

Publication Number Publication Date
AU2001273102A1 true AU2001273102A1 (en) 2002-01-14

Family

ID=24436097

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001273102A Abandoned AU2001273102A1 (en) 2000-06-29 2001-06-29 Crystal structure of survivin

Country Status (2)

Country Link
AU (1) AU2001273102A1 (en)
WO (1) WO2002002622A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004236636B2 (en) * 2003-03-24 2010-02-04 The Scripps Research Institute DNA vaccines against tumor growth and methods of use thereof
US7252090B2 (en) 2003-09-15 2007-08-07 Medtronic, Inc. Selection of neurostimulator parameter configurations using neural network
US20070104689A1 (en) * 2005-09-27 2007-05-10 Merck Patent Gmbh Compositions and methods for treating tumors presenting survivin antigens
US8380300B2 (en) 2006-04-28 2013-02-19 Medtronic, Inc. Efficacy visualization
US7715920B2 (en) 2006-04-28 2010-05-11 Medtronic, Inc. Tree-based electrical stimulator programming
US8306624B2 (en) 2006-04-28 2012-11-06 Medtronic, Inc. Patient-individualized efficacy rating
US8710068B2 (en) 2009-01-19 2014-04-29 The Trustees Of The University Of Pennsylvania Method of treating cancer using a survivin inhibitor
FR2955112B1 (en) * 2010-01-14 2012-01-20 Isp Investments Inc NOVEL SURVIVIN MODULATING ANTI-AGING PEPTIDES AND COMPOSITIONS COMPRISING THE SAME

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100645448B1 (en) * 1996-11-20 2006-11-13 예일 유니버시티 Survivin, a protein that inhibit cellular apoptosis, and its modulation

Also Published As

Publication number Publication date
WO2002002622A3 (en) 2002-09-12
WO2002002622A2 (en) 2002-01-10

Similar Documents

Publication Publication Date Title
AU2000269903A1 (en) Mechanical connection of panels
AU2002218266A1 (en) Novel indanylidene compounds
AU2001292518A1 (en) Novel compounds
AU2002330453A1 (en) Crystals of hydroxynorephedrine derivative
AU2001244692A1 (en) Novel crystal form of pyrrolidylthiocarbapenem derivative
AU2002255801A1 (en) Polarization to phase converter
AU2001239765A1 (en) Novel compounds
AU2001281965A1 (en) Novel 6-phenylphenanthridines
AU2001246998A1 (en) Novel compounds
AU2001253362A1 (en) Novel compounds
AU2001269685A1 (en) Crystallization of 4-diphosphocytidyl-2-c-methylerythritol synthesis
AU2002231077A1 (en) Novel compounds
AU2001256964A1 (en) Novel compounds
AU2001273102A1 (en) Crystal structure of survivin
AU2002356615A1 (en) Novel utilization of cyclopentabenzofurans
AU2001265935A1 (en) Production of biohydrolysates
AU2002213362A1 (en) Novel substituted-polyaryl chromophoric compounds
AU2002221923A1 (en) Novel compounds
AU2002216060A1 (en) Novel compounds
AU2002358357A1 (en) Improvements relating to frequency synthesis
AU2001276890A1 (en) Novel compounds
AU7711800A (en) Novel uses of 2-bromopalmitate
AU2001290731A1 (en) Structural prediction of allosterism
AU2001258760A1 (en) Novel thiophenamide compounds
AU2001237533A1 (en) Novel p-gp-inhibiting compounds